Before Lourie, Prost, and Reyna. Appeal from the U.S. District Court for the District of Delaware. Summary: A patent was not invalid for lack of written description for failing to describe the specific infringing embodiment...more
1/20/2025
/ Appellate Courts ,
Claim Construction ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Written Descriptions
UCB, INC. v. ACTAVIS LABORATORIES UT, INC.
Before Moore, Chen, and Stoll. Appeal from the U.S. District Court for the District of Delaware.
Summary: District court legally erred by applying incorrect anticipation...more
ARBUTUS BIOPHARMA CORPORATION v. MODERNATX, INC.
Before Reyna, Schall, and Chen. Appeal from the Patent Trial and Appeal Board.
Summary: Arbutus’ patent was anticipated by an earlier Arbutus patent that incorporated...more